Cangrelor vs. Glycoprotein IIb/IIIa Inhibitors During Percutaneous Coronary Intervention. Yerasi C, Case BC, Chezar-Azerrad C, Forrestal BJ, et al. Am Heart J 2021 May 4. pii: S0002-8703(21)00115.

Read + Share

Amedeo Smart

Independent Medical Education

Yerasi C, Case BC, Chezar-Azerrad C, Forrestal BJ, et al. Cangrelor vs. Glycoprotein IIb/IIIa Inhibitors During Percutaneous Coronary Intervention. Am Heart J 2021 May 4. pii: S0002-8703(21)00115.
PMID: 33961829